Mandate

Vinge advised ZetaDisplay on bond issue

The bonds are intended to be listed on Nasdaq Stockholm.
 
Vinge acted as legal adviser to ZetaDisplay. The Vinge team included partners Erik Sjöman and Christian Lindhé, and associates Fredrik Christiansson and Martin Svanberg.  

Sept. 12, 2019

Vinge advised Enea on directed share issue

The Vinge team was headed by capital markets and public M&A partners Erik Sjöman and Christian Lindhé and also included Nora Gullberg.
 

Aug. 26, 2019

Vinge advises Cantargia on directed share issue

Vinge advises Cantargia. The Vinges team includes Erik Sjöman, Christian Lindhé and Ludvig Frithiof.

March 25, 2019

Vinge advises Active Biotech on real estate transaction

Vinge advises Active Biotech. Vinge’s team is primarily composed of Erik Sjöman, Anna Edström, Christian Lindhé and Jessica Salomonsson. 

March 14, 2019

Vinge advises Fagerhult

After closing of the transaction, the intention is that Fagerhult will repay a bridge loan, raised to finance such part of the consideration that is not payable in Fagerhult shares, with the proceeds from a rights offering of approx. EUR 220 million.

Vinge and others advise Fagerhult. The Vinge team includes Erik Sjöman, Christian Lindhé and Ludvig Frithiof.

Jan. 8, 2019

Vinge advised Cantargia on its Nasdaq Stockholm main market listing

The Vinge team included Erik Sjöman, Christian Lindhé, Astrid Isberg and Martin Svanberg.

Sept. 25, 2018

Vinge advised IBT on its Nasdaq Stockholm main market listing

 Vinge advised IBT.

The Vinge team included Erik Sjöman, Christian Lindhé and Astrid Karlsson..
 

Sept. 10, 2018

Vinge advised BIMobject on directed share issue

Vinge advised BIMobject. The Vinge team included Erik Sjöman, Christian Lindhé and Astrid Karlsson.

July 11, 2018

Vinge advised Lifco on bond issue

The bonds were listed on Nasdaq Stockholm 19 April 2018.

Vinge acted as legal advisor to Lifco. Vinge’s team consisted of Erik Gabrielson, Christian Lindhé and Carl Öberg.
 

May 2, 2018

Vinge advises Wilson Therapeutics in connection with the offer from Alexion


The offer values Wilson Therapeutics at approximately SEK 6,564 million. 
 
Vinge advises Wilson Therapeutics in connection with the offer. Vinge’s team is primarily composed of Erik Sjöman, Christian Lindhé, Astrid Karlsson and Philip Åberg. 

April 11, 2018

Vinge advises Enea

Vinge advises Enea. The Vinge team includes Erik Sjöman, Henrik Ossborn, Christian Lindhé, Fredrik Christiansson, Astrid Karlsson and Carl Öberg.
 

March 4, 2018

Vinge advises Active Biotech on rights offering

The Vinge team includes Erik Sjöman, Christian Lindhé, Astrid Karlsson and Jack Bengtsson.
 

Feb. 15, 2018

Vinge advised Medivir on its directed share issue

The Vinge team included Erik Sjöman, Christan Lindhé and Ludvig Frithiof.

Feb. 5, 2018

Vinge advises Tempest Security in connection with listing on Nasdaq First North

Vinge’s team was primarily composed of Christian Lindhé, Kristoffer Franzkeit, Ludvig Frithiof and Freja Ljungdell Kristensen.   

 

Dec. 12, 2017

Vinge advises Wilson Therapeutics in connection with directed share issue

The share issue is directed to a number of selected institutions and sector specialist funds, internationally and in Sweden, on the basis of an accelerated bookbuilding process.

Vinge’s team consisted of Christian Lindhé, Erik Sjöman, Mattias Sköld, Ludvig Frithiof and Astrid Karlsson.

Dec. 12, 2017

Vinge advised Lifco on bond issue


The bonds were listed on Nasdaq Stockholm on 6 December 2017.

Vinge acted as legal advisor to Lifco. The Vinge team primarily consisted of Christian Lindhé and Carl Öberg, together with Erik Sjöman, Henrik Ossborn and Fredrik Christiansson.

 

Dec. 7, 2017

Vinge advises IBT on share issues

The Vinge team includes Erik Sjöman, Christian Lindhé, Kristoffer Franzkeit, Ludvig Frithiof and Astrid Karlsson.

Nov. 24, 2017

Vinge advises Cantargia on share issues

The Vinge team includes Erik Sjöman, Christian Lindhé, Kristoffer Franzkeit and Ludvig Frithiof.

Nov. 10, 2017

Vinge advised Orexo on bond issue

The bonds are intended to be listed on Nasdaq Stockholm.
 
Vinge acted as legal adviser to Orexo. The Vinge team included partners Erik Sjöman and Henrik Ossborn, and associates Christian Lindhé, Fredrik Christiansson and Astrid Karlsson.  
 

Nov. 2, 2017

Vinge advised Enea on directed share issue

The Vinge team was headed by capital markets and public M&A partner Erik Sjöman and included Christan Lindhé and Astrid Karlsson.

Oct. 26, 2017

Vinge advises Trianon 

Vinge’s team primarily consisted of Erik Sjöman, Anna Edström, Christian Lindhé and Astrid Karlsson.

June 26, 2017

Vinge advised Enea on directed share issue

Vinge has advised Enea AB (publ) in connection with a directed share issue of SEK 162.4 million through an accelerated book-building procedure.

The Vinge team was headed by capital markets and public M&A partner Erik Sjöman and included Christan Lindhé and Astrid Karlsson.

Feb. 28, 2017

Vinge advises Cantargia on rights offering

Vinge advises Cantargia AB (publ) (Nasdaq First North) in connection with a rights offering of approximately SEK 91 million.

The Vinge team includes Erik Sjöman, Christian Lindhé, Kristoffer Franzkeit and Ludvig Frithiof.

Dec. 21, 2016

Vinge advises Active Biotech on rights offering

Active Biotech AB (publ) (Nasdaq Stockholm) carries out a rights issue of approximately SEK 55 million.
 
Vinge advises Active Biotech. Vinge’s team primarily consists of Erik Sjöman, Christian Lindhé, Ludvig Frithiof and Astrid Karlsson.

Nov. 15, 2016

Vinge advises Platzer Fastigheter in conjunction with the acquisition of AB Volvos real estate portfolio in Gothenburg

The underlying real estate value amounts to approximately SEK 2.8 billion. The acquired portfolio consists of 338,000 square meters of rentable area as well as land located in Arendal, Torslanda and Säve. The ground area amounts to approximately 3.6 million square meters. The preliminary closing date is 15 December 2016. In order to finance part of the acquisition, Platzer intends to carry out a rights issue of approximately SEK 700 million. In connection with the acquisition, Platzer also intends to utilize bank financing of up to approximately SEK 1.7 billion. Vinge has advised Platzer in all parts of the transaction.

Vinge’s team consisted of partners Olof Jisland, Assur Badur, Charlotte Levin, Louise Brorsson Salomon, counsel Johan Cederblad, partner Robert Deli, associates Christian Lindhé, Anna-Maria Terzi, Anna Lonergan, Ludvig Frithiof, Kristoffer Larsson, Marith Welin-Berger, Emelie Parland and Frida Ställborn.

Oct. 25, 2016

Vinge has assisted Enea AB (publ) in the acquisition of Qosmos S.A.

Vinge has assisted Enea AB (publ) in the acquisition of the French company Qosmos S.A., active in the development of software for Network Intelligence and a market leader within the field of Deep Packet Inspection (DPI).

Vinge's team consisted of Jesper Ottergren, assisted by Christian Lindhé and Karolina Tjärnberg. Henrik Ossborn and Fredrik Christiansson assisted in relation to the bank financing of the transaction.

Oct. 24, 2016

Vinge advised Elanders

Vinge has advised Elanders AB (publ) in connection with the acquisition of the German supply chain management company LGI Logistics Group International GmbH and advises in connection with the rights issue of approximately SEK 700 million that is made to partly finance the acquisition.

Vinge’s team includes Erik Gabrielson, Erik Sjöman, Christian Lindhé, Ludvig Frithiof and Astrid Karlsson.

Sept. 2, 2016

Vinge advises Apsis Group AB in its acquisition of Innometrics AB

Vinge advises Apsis Group AB in connection with its acquisition of Innometrics AB. Innometrics develops and sells data-driven digital marketing services allowing the customer to merge data from various sources, which is an area that Apsis, with its focus on email and marketing automation, has also focused on.

Vinge’s team consisted of partners Henrik Borna and Anna Edström, counsel Christian Lindhé and, among others, associates Emelie Svensäter Jerntorp, Mattias Sköld and Fredrik Lasson.

June 22, 2016

Vinge advises AcadeMedia in relation to its listing on Nasdaq Stockholm

Vinge advises AcadeMedia AB (publ) and selling shareholders in relation to AcadeMedia’s listing on Nasdaq Stockholm. Trading in the AcadeMedia share on Nasdaq Stockholm commences today, June 15 2016. The price in the offering was set at SEK 40 per share, which corresponds to a value of the total number of shares in the company upon completion of the offering of SEK 3,764 million. Assuming the over-allotment option is exercised in full, the value of the offering will amount to approximately SEK 1,093 million.

AcadeMedia is the leading and single largest independent education provider in northern Europe. In 2014/15, approximately 62,000 children and students attended AcadeMedia’s preschools, compulsory schools and upper secondary schools. An additional 80,000 individuals participated in AcadeMedia’s adult education courses. In 2014/15, AcadeMedia had approximately 400 preschools, compulsory schools and upper secondary schools in Sweden and Norway and approximately 150 adult education units in Sweden. AcadeMedia also has seven preschools in the Munich region of Germany. AcadeMedia has operations throughout the education chain, from preschool, compulsory school and upper secondary school to adult education.

Vinge’s team primarily consists of Erik Sjöman, Dain Hård Nevonen, Christian Lindhé, Ludvig Frithiof, Sofie Bjärtun, Nils Fredrik Dehlin and Astrid Karlsson. Maria Schultzberg and Emelie Parland advise on tax matters.

June 15, 2016

Vinge advised in the offer for Qlik Technologies

Vinge has acted as Swedish counsel to Qlik Technologies Inc. in connection with Thoma Bravo’s offer to acquire the company. Qlik Technologies is listed on Nasdaq Global Select Market and the offer values Qlik Technologies to approximately USD 3 billion.

Vinge’s team was composed of Henrik Borna and Christian Lindhé.

June 3, 2016

Vinge advised Wilson Therapeutics in connection with its IPO

Vinge has advised Wilson Therapeutics AB (publ) in connection with its IPO on Nasdaq Stockholm. The price in the offering was set at SEK 49 per share, corresponding to a
market capitalization of approximately SEK 1,305 million for the total number of outstanding shares in the company (provided that the over-allotment option is utilized).

Vinge’s team primarily consisted of Jesper Ottergren, Erik Sjöman, Christian Lindhé, Ludvig Frithiof, Kristoffer Franzkeit and Astrid Karlsson.

May 12, 2016

Vinge advised Orexo on its divestment of Kibion

Orexo AB (publ) (Nasdaq Stockholm) has divested its subsidiary Kibion to a group of investors. Vinge advised Orexo.

The Vinge team included Erik Sjöman (partner, capital markets and M&A) and associates Christian Lindhé, Kristoffer Franzkeit and Cecilia Cronqvist.

May 4, 2015

Vinge advised Lifco on bond issue

Lifco AB (publ) (Nasdaq Stockholm) has issued three-year unsecured bonds of in total SEK 1,050 million. The bonds are to be listed on Nasdaq Stockholm.                     
 
Vinge acted as legal adviser to Lifco. The Vinge team included partners Erik Sjöman (capital markets and public M&A) and Henrik Ossborn (banking & finance), and associates Christian Lindhé (capital markets and public M&A), Fredrik Christiansson (banking & finance) and Ludvig Frithiof (capital markets and public M&A).


 

March 25, 2015

Vinge advises on Serstech’s rights issue

Vinge has advised Serstech AB (publ) in connection with its rights issue.

Vinge’s team consisted of partner Jesper Ottergren and associate Christian Lindhé.

Jan. 12, 2015

Vinge advises Active Biotech on rights offering

Active Biotech AB (publ) (Nasdaq Stockholm) carries out a rights offering of SEK 225 million. Vinge advises Active Biotech.

The Vinge team primarily consists of Erik Sjöman (partner, capital markets & public M&A) and associates Christian Lindhé, Ludvig Frithiof and Madelene Eriksson.

Nov. 24, 2014

Vinge advised Lifco on IPO

The class B shares of Lifco AB (publ) have been admitted to trading on the main market of Nasdaq Stockholm, following an offering to the general public in Sweden and to institutional investors in Sweden and abroad. The price in the offering was SEK 93 per share, corresponding to a market value of all Lifco shares of approximately SEK 8.4 billion.

Vinge advised Lifco. The Vinge team primarily consisted of Erik Gabrielson, Erik Sjöman, Jesper Schönbeck, Anna Edström and Christian Lindhé, together with a large number of other associates and specialist partners.

Nov. 21, 2014

VINGE ADVISES ADVENICA IN CONNECTION WITH LISITNG ON FIRST NORTH

Vinge has advised Advenica AB (publ) in connection with its listing on NASDAQ OMX First North Premier.

Vinge’s team primarily consisted of partners Jesper Ottergren and Erik Sjöman together with associates Christian Lindhé, Carl Fahleryd and Kristoffer Franzkeit.

Sept. 19, 2014

Vinge advised Orexo on private placement

Orexo AB (publ) (NASDAQ OMX Stockholm) has completed a private placement of Orexo shares to qualified investors, resulting in total cash proceeds of approximately SEK 346.5 million before transaction costs.

Vinge acted as legal adviser to Orexo. The Vinge team included Erik Sjöman (partner, capital markets and public M&A) and associates Christian Lindhé, Rikard Lindahl and Madelene Eriksson.

 

 

Sept. 4, 2014

Vinge advised in Elanders’ rights offering

Elanders AB (publ) (NASDAQ OMX Stockholm) has made a SEK 125 million fully underwritten rights offering. Vinge advised Elanders.

The Vinge team included partners Erik Gabrielson and Erik Sjöman and associates Christian Lindhé and Madelene Eriksson.

May 11, 2014

Vinge advised Orexo on bond issue

Orexo AB (publ) (NASDAQ OMX Stockholm) has issued a four-year senior unsecured bond loan of SEK 500 million, with the possibility to issue a further SEK 500 million of bonds. The bonds are to be listed on NASDAQ OMX Stockholm.                      

Vinge acted as legal adviser to Orexo. The Vinge team included partners Erik Sjöman (capital markets and public M&A) and Henrik Ossborn (banking & finance), and associates Christian Lindhé (capital markets and public M&A) and Fredrik Christiansson (banking & finance).

May 2, 2014

VINGE ADVISES CREADES IN CONNECTION WITH ITS LISTING ON NASDAQ OMX STOCKHOLM’S MAIN MARKET

Creades AB (publ) (NASDAQ OMX First North) has been approved for listing on NASDAQ OMX’s main market. The first day of trading was 6 December 2013.

Vinge’s team primarily consisted of partner Erik Sjöman and associates Jo-Anna Nordström, Christian Lindhé and Rikard Lindahl. Associates Maria Schultzberg and Maria Doeser advised in relation to tax matters.

Dec. 5, 2013

Vinge advises bong in connection with new issues

Bong AB (publ) (NASDAQ OMX Stockholm) has carried out a fully underwritten rights issue, a directed placement of convertible bonds to certain qualifying investors and set-off issues to certain creditors. The aggregate amount issued is approximately SEK 475 million.  Vinge advised Bong.

Vinge’s team primarily consisted of Erik Sjöman, Peter Oscarsson, Christian Lindhé, Fabian Ekeblad, Albert Wållgren and Henrik Jonsson.

Oct. 14, 2013

Vinge advises MultiQ International AB on the acquisition of Public Systems Nordic AB

Vinge advises MultiQ International AB, listed on Nasdaq OMX Small Cap, in connection with the acquisition of Public Systems Nordic AB and the SEK 15m new issue of shares with preferential rights conducted in connection with the acquisition. Through the acquisition, Sweden’s largest company within monitor solutions for public spaces, so called Digital Signage, is created. The purchase price for the acquisition of Publiq is paid through the issuance of new shares in MultiQ.

The Vinge team advising MultiQ International AB includes partner Jesper Ottergren and, among others, associates Marcus Bergdahl and Christian Lindhé. Further, partner Erik Sjöman provides advice on capital markets regulations and Ingela Malmborg provides employment law advice.

Aug. 30, 2013

Vinge advises Active Biotech in relation to directed new share issue

In March this year, Active Biotech AB (publ) conducted a directed new share issue to Investor AB (publ) pursuant to which Active Biotech procured SEK 270 million.

Vinge’s team consisted of partner Erik Sjöman and associate Christian Lindhé.

April 4, 2013